Ajanta Pharma informs about investor meetings

17 Aug 2023 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that it enclosed the schedule of Analyst/Institutional Investor Meetings with the Company. The company has confirmed that the discussion during these meetings will be strictly on the basis of already published information and no Unpublished Price Sensitive Information is proposed to be discussed in these meetings.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2215.00 5.30 (0.24%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.